Herbalife Ltd. (HLF) stock
HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 9/3042% below fair value
$15.57−0.58 (-3.59%)
Close on Nov 17, 2026Market cap $1.63BP/E 10.0Yield –
Herbalife ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Herbalife's ebitda for the twelve months ending Jun 30, 2026 was $613.10M, up 0.5% year over year. For fiscal 2025 it was $602.20M, up 18.7% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is $841.70M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $602.20M | +18.7% |
| FY2024 | Dec 31, 2024 | $507.30M | +8.0% |
| FY2023 | Dec 31, 2023 | $469.70M | -28.9% |
| FY2022 | Dec 31, 2022 | $660.60M | -21.5% |
| FY2021 | Dec 31, 2021 | $841.70M | +13.6% |
| FY2020 | Dec 31, 2020 | $740.90M | +11.3% |
| FY2019 | Dec 31, 2019 | $665.80M | -15.0% |
| FY2018 | Dec 31, 2018 | $783.50M | +9.3% |
| FY2017 | Dec 31, 2017 | $716.90M | +28.8% |
| FY2016 | Dec 31, 2016 | $556.40M | -18.4% |
| FY2015 | Dec 31, 2015 | $681.60M | +12.3% |
| FY2014 | Dec 31, 2014 | $606.70M | -26.0% |
| FY2013 | Dec 31, 2013 | $820.00M | +11.4% |
| FY2012 | Dec 31, 2012 | $735.80M | +16.0% |
| FY2011 | Dec 31, 2011 | $634.12M | +39.0% |
| FY2010 | Dec 31, 2010 | $456.13M | +27.2% |
| FY2009 | Dec 31, 2009 | $358.47M | -5.9% |
| FY2008 | Dec 31, 2008 | $380.98M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $159.70M | -2.1% |
| Q1 FY2026 | Mar 31, 2026 | $167.80M | +9.3% |
| Q4 FY2025 | Dec 31, 2025 | $129.10M | -4.7% |
| Q3 FY2025 | Sep 30, 2025 | $156.50M | -0.8% |
| Q2 FY2025 | Jun 30, 2025 | $163.10M | +44.3% |
| Q1 FY2025 | Mar 31, 2025 | $153.50M | +51.8% |
| Q4 FY2024 | Dec 31, 2024 | $135.50M | +61.3% |
| Q3 FY2024 | Sep 30, 2024 | $157.70M | +16.7% |
| Q2 FY2024 | Jun 30, 2024 | $113.00M | -25.9% |
| Q1 FY2024 | Mar 31, 2024 | $101.10M | +3.1% |
| Q4 FY2023 | Dec 31, 2023 | $84.00M | -28.3% |
| Q3 FY2023 | Sep 30, 2023 | $135.10M | -23.2% |
| Q2 FY2023 | Jun 30, 2023 | $152.50M | -17.7% |
| Q1 FY2023 | Mar 31, 2023 | $98.10M | -46.2% |
| Q4 FY2022 | Dec 31, 2022 | $117.10M | +4.7% |
| Q3 FY2022 | Sep 30, 2022 | $176.00M | -18.5% |
| Q2 FY2022 | Jun 30, 2022 | $185.20M | -30.1% |
| Q1 FY2022 | Mar 31, 2022 | $182.30M | -26.8% |
| Q4 FY2021 | Dec 31, 2021 | $111.80M | -35.9% |
| Q3 FY2021 | Sep 30, 2021 | $216.00M | -6.6% |
| Q2 FY2021 | Jun 30, 2021 | $265.00M | +23.0% |
| Q1 FY2021 | Mar 31, 2021 | $248.90M | +107.8% |
| Q4 FY2020 | Dec 31, 2020 | $174.40M | +31.4% |
| Q3 FY2020 | Sep 30, 2020 | $231.30M | +37.7% |
| Q2 FY2020 | Jun 30, 2020 | $215.40M | +21.2% |
| Q1 FY2020 | Mar 31, 2020 | $119.80M | -36.1% |
| Q4 FY2019 | Dec 31, 2019 | $132.70M | -23.1% |
| Q3 FY2019 | Sep 30, 2019 | $168.00M | -20.9% |
| Q2 FY2019 | Jun 30, 2019 | $177.70M | -18.1% |
| Q1 FY2019 | Mar 31, 2019 | $187.40M | +3.3% |
| Q4 FY2018 | Dec 31, 2018 | $172.60M | -1.4% |
| Q3 FY2018 | Sep 30, 2018 | $212.50M | +47.1% |
| Q2 FY2018 | Jun 30, 2018 | $217.00M | -5.2% |
| Q1 FY2018 | Mar 31, 2018 | $181.40M | +7.8% |
| Q4 FY2017 | Dec 31, 2017 | $175.10M | -4.8% |
| Q3 FY2017 | Sep 30, 2017 | $144.50M | -18.0% |
| Q2 FY2017 | Jun 30, 2017 | $229.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $168.30M | – |
| Q4 FY2016 | Dec 31, 2016 | $183.90M | – |
| Q3 FY2016 | Sep 30, 2016 | $176.20M | – |
See a number that looks wrong?